Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Starting on:
Feb 21, 2019
Ending on:
Feb 22, 2019
Moderator(s):
Venue:
MP Shah Hospital,Shivachi Road
Max Credits:
3 Points

Provider:
MP Shah Hospital
Claim Points

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

Starting on:
Feb 21, 2019 7:30 AM
Ending on:
Feb 22, 2019 9:00 AM
Venue:
MP Shah Hospital,Shivachi Road

Description

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

Objectives

Comparison cardiovascular outcomes associated with Febuxostat and Allopurinol in patients with Gout

Presenters

  1. Dr. Shamsa Ahmed
    Senior Registrar MP Shah Hospital Nairobi
    MP Shah Hospital

Search For CPD Activity